Status:
TERMINATED
Sound Conduction of Infant Hips
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
University of Central Florida
Conditions:
Developmental Dysplasia of the Hip
Eligibility:
All Genders
1-6 years
Phase:
NA
Brief Summary
The objective of this study is to collect data that will be used to later design a method for the early diagnosis of diagnosis of developmental dysplasia of the hip (DDH).
Detailed Description
This will be a prospective study using an acoustic listening technique in combination with a standard clinical examination of DDH. For both the clinical cases and healthy children that are enrolled, ...
Eligibility Criteria
Inclusion
- Infants included in this study must be born at full term with a gestational age of 0-6 months
- Infants of both genders will be included
- Infants must have been screened for DDH.
Exclusion
- Infants born prematurely
- Infants greater than six months of age.
- Nonviable neonates and neonates of uncertain viability
Key Trial Info
Start Date :
March 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 6 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT05188235
Start Date
March 10 2022
End Date
October 6 2023
Last Update
November 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016